{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T23:06:43Z","timestamp":1776553603690,"version":"3.51.2"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.eclinm.2025.103585","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T07:53:43Z","timestamp":1761378823000},"page":"103585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Full-length merozoite surface protein 1 formulated with GLA-SE adjuvant in malaria pre-exposed adults: a randomised, controlled, double-blind, parallel-group, single-centre Phase Ib trial"],"prefix":"10.1016","volume":"89","author":[{"given":"Aina-ekisha","family":"Kahatano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxmillian","family":"Mpina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Vanobberghen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omary","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nsiande","family":"Urasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Sasamalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Mswata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Paris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne","family":"Gajewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meera","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"F\u00fcrle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Kiehl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"B\u00f6hnlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Aschenbrenner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lanzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Thomson-Luque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6696-1937","authenticated-orcid":false,"given":"Ally","family":"Olotu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7136-0642","authenticated-orcid":false,"given":"Claudia","family":"Daubenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2025.103585_bib1","series-title":"World malaria report 2024","year":"2024"},{"key":"10.1016\/j.eclinm.2025.103585_bib2","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/S0140-6736(23)01249-7","article-title":"Malaria","volume":"402","author":"Poespoprodjo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2025.103585_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1126\/science.adl1805","article-title":"Second malaria vaccine gets WHO green light","volume":"382","author":"Vogel","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.eclinm.2025.103585_bib4","series-title":"WHO recommends groundbreaking malaria vaccine for children at risk","year":"2021"},{"key":"10.1016\/j.eclinm.2025.103585_bib5","series-title":"Malaria vaccines: preferred product characteristics and clinical development considerations","year":"2022"},{"key":"10.1016\/j.eclinm.2025.103585_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/14760584.2023.2295430","article-title":"Plasmodium falciparum merozoite surface protein 1 as asexual blood stage malaria vaccine candidate","volume":"23","author":"Thomson-Luque","year":"2023","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.eclinm.2025.103585_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016333","article-title":"Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant","volume":"6","author":"Coler","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2025.103585_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41541-020-0160-2","article-title":"Immunization with full-length Plasmodium falciparum merozoite surface protein 1 is safe and elicits functional cytophilic antibodies in a randomized first-in-human trial","volume":"5","author":"Blank","year":"2020","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.eclinm.2025.103585_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41541-023-00701-2","article-title":"Multifunctional IgG\/IgM antibodies and cellular cytotoxicity are elicited by the full-length MSP1 SumayaVac-1 malaria vaccine","volume":"8","author":"Rosenkranz","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.eclinm.2025.103585_bib10","series-title":"Stata statistical software: release 18","year":"2023"},{"key":"10.1016\/j.eclinm.2025.103585_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.chom.2015.09.007","article-title":"Processing of Plasmodium falciparum Merozoite Surface Protein MSP1 activates a spectrin-binding function enabling parasite egress from RBCs","volume":"18","author":"Das","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.eclinm.2025.103585_bib12","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.immuni.2024.02.017","article-title":"Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants","volume":"57","author":"Johnston","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.eclinm.2025.103585_bib13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.immuni.2025.02.004","article-title":"Early influenza virus exposure shapes the B cell response to influenza vaccination in individuals 50 years later","volume":"58","author":"Spangler","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.eclinm.2025.103585_bib14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/192733a0","article-title":"Gamma-globulin and acquired immunity to human malaria","volume":"192","author":"Cohen","year":"1961","journal-title":"Nature"},{"key":"10.1016\/j.eclinm.2025.103585_bib15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4269\/ajtmh.1991.45.297","article-title":"Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria","volume":"45","author":"Sabchareon","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.eclinm.2025.103585_bib16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.12688\/wellcomeopenres.14909.1","article-title":"Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity","volume":"3","author":"Kapulu","year":"2018","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.eclinm.2025.103585_bib17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.immuni.2024.05.001","article-title":"Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge","volume":"57","author":"Nkumama","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.eclinm.2025.103585_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S0031182015001778","article-title":"Naturally acquired immunity to malaria","volume":"143","author":"Barry","year":"2016","journal-title":"Parasitology"},{"key":"10.1016\/j.eclinm.2025.103585_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","article-title":"Malaria vaccines: recent advances and new Horizons","volume":"24","author":"Draper","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.eclinm.2025.103585_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.immuni.2015.02.012","article-title":"Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria","volume":"42","author":"Boyle","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.eclinm.2025.103585_bib21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41467-019-08528-z","article-title":"Targets of complement-fixing antibodies in protective immunity against malaria in children","volume":"10","author":"Reiling","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.eclinm.2025.103585_bib22","doi-asserted-by":"crossref","first-page":"eabn5993","DOI":"10.1126\/scitranslmed.abn5993","article-title":"Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria","volume":"15","author":"Odera","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.eclinm.2025.103585_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074627","article-title":"Opsonising antibodies to P. falciparum merozoites associated with immunity to clinical malaria","volume":"8","author":"Hill","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2025.103585_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1741-7015-12-108","article-title":"Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria","volume":"12","author":"Osier","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.eclinm.2025.103585_bib25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s42003-021-02511-5","article-title":"Neutrophils dominate in opsonic phagocytosis of P. falciparum blood-stage merozoites and protect against febrile malaria","volume":"4","author":"Garcia-Senosiain","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.eclinm.2025.103585_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009871","article-title":"Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies","volume":"5","author":"Joos","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.eclinm.2025.103585_bib27","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202301910","article-title":"Full-length MSP1 is a major target of protective immunity after controlled human malaria infection","volume":"7","author":"Rosenkranz","year":"2024","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.eclinm.2025.103585_bib28","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1371\/journal.pmed.0040093","article-title":"Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali","volume":"4","author":"Takala","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.eclinm.2025.103585_bib29","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.chom.2020.07.001","article-title":"Antibody feedback limits the expansion of B cell responses to malaria vaccination but drives diversification of the humoral response","volume":"28","author":"McNamara","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.eclinm.2025.103585_bib30","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1038\/s41467-022-33336-3","article-title":"Neutralizing and interfering human antibodies define the structural and mechanistic basis for antigenic diversion","volume":"13","author":"Patel","year":"2022","journal-title":"Nat Commun"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025005188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T05:33:29Z","timestamp":1769060009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025005188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"alternative-id":["S2589537025005188"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103585","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Full-length merozoite surface protein 1 formulated with GLA-SE adjuvant in malaria pre-exposed adults: a randomised, controlled, double-blind, parallel-group, single-centre Phase Ib trial","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103585"}}